[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"anemia-of-prematurity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:anemia-of-prematurity":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100558760","pilot-trial-investigating-every-other-day-dosing-of-oral-iron-in-premature-infants-iqonic-100558760",false,"NCT06555315","Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)","Pilot Non-inferiority Study Investigating Daily Versus Every Other Day Dosing of Oral Iron in Premature Infants.","Inclusion Criteria:\n\n* Children (Minor \\\u003C 18 years of age)\n* Neonates\n* Hospitalized\n* Premature infants who are on full enteral feeds and are started on oral iron\n* Premature infants who completed 26 0\u002F7 to 32 6\u002F7 weeks' gestation at birth\n\nExclusion Criteria:\n\n• Infants with known congenital anomalies or chromosomal abnormalities (such as Trisomy 18 or Trisomy 21), conditions that affect iron metabolism (such as thalassemia or hemochromatosis), bleeding disorders or coagulopathy, and received iron parenterally prior to randomization",true,"ALL","26 Weeks","32 Weeks",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates",[28,29,30,31,32],"Very Low Birth Weight Infant","Premature Infants","Anemia of Prematurity","Iron Deficiency, Anaemia in Children","Extremely Low Birth Weight",[34,35,36,37],"Premature infants","Iron","anemia of prematurity","iron deficiency","RECRUITING","2024-08-13",{"date":41,"type":42},"2024-08-15","ACTUAL",{"date":44,"type":42},"2024-08-01",{"date":46,"type":22},"2026-03-28",{"name":48,"class":49},"CHRISTUS Health","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":23,"phases":61,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":50},"100533026","folic-acid-supplementation-to-reduce-anemia-in-extremely-preterm-infants-100533026","NCT06220461","Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants","Folic Acid Supplementation to Reduce the Severity of Anemia and Blood Transfusions in Extremely Preterm Infants","FASCINATE","Inclusion Criteria:\n\n* Infants born at \\\u003C29 weeks of gestational age admitted to Foothill Medical Centre.\n* Postnatal age 14 days.\n* On minimum enteral feeding of 100 mL\u002Fkg\u002Fday\n\nExclusion Criteria:\n\n* Infants with major congenital or chromosomal anomalies\n* Infants with ongoing pulmonary or gastroenterology hemorrhage by 14 days of life.",{"count":60,"type":22},90,[25],"Anemia of Prematurity (AOP) is very common in extremely preterm infants and often leads to blood transfusions. Folic acid, essential for growth and DNA synthesis, is deficient in premature infants. Despite the adoption of folic acid supplementation, evidence supporting its effectiveness in preventing AOP remains scarce. Recommendations for folic acid intake exceed what's naturally found in breast milk, particularly for extremely low birthweight infants. Practices regarding folic acid supplementation vary widely, prompting the need for research. The FACINATE trial aims to determine if additional folic acid supplementation improves hemoglobin levels and reduces late blood transfusions in extremely preterm infants, a question not addressed in current literature.",[64,30],"Extreme Prematurity",[66,67,36,68],"extreme preterm","folic acid deficiency","neonatal blood transfusion","NOT_YET_RECRUITING","2024-05-08",{"date":72,"type":42},"2024-05-09",{"date":74,"type":22},"2024-06-01",{"date":76,"type":22},"2028-07-31",{"name":78,"class":49},"University of Calgary"]